DOI: 10.1111/1753-0407.70259 ISSN: 1753-0393

Limited Comparative Evidence Between Metabolic Bariatric Surgery and Incretin‐Based Pharmacotherapy for Weight Loss in Type 2 Diabetes: A Systematic Review and Meta‐Analysis

Oqab Baniowdeh, Ahmad Arar, Yusuf Muslih, Tala Obeidat, Eliana Marji, Shahed Elghandour, Jalal Jbara, Lela Shengelia

Summary

Current comparative evidence between metabolic bariatric surgery and incretin‐based pharmacotherapy for weight loss in adults with type 2 diabetes remains limited. Our systematic review and meta‐analysis suggests greater weight loss following metabolic bariatric surgery while highlighting the urgent need for high‐quality prospective head‐to‐head comparative studies.

More from our Archive